Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(19):1466-1474; doi:10.1093/jnci/dji293
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Chang, E. T.
Right arrow Articles by Adami, H.-O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, E. T.
Right arrow Articles by Adami, H.-O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

ARTICLE

Family History of Hematopoietic Malignancy and Risk of Lymphoma

Ellen T. Chang, Karin Ekström Smedby, Henrik Hjalgrim, Anna Porwit-MacDonald, Göran Roos, Bengt Glimelius, Hans-Olov Adami

Affiliations of authors: Department of Medical Epidemiology and Biostatistics (ETC, KES, H-OA) and Department of Oncology and Pathology (AP-M, BG), Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology Research, Danish Epidemiology Science Center, Statens Serum Institut, Copenhagen, Denmark (HH); Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden (GR); Department of Oncology, Radiology and Clinical Immunology, University of Uppsala, Uppsala, Sweden (BG)

Correspondence to: Ellen T. Chang, ScD, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, SE-171 77, Stockholm, Sweden (e-mail: ellen.chang{at}meb.ki.se).

Background: A family history of hematopoietic malignancy is associated with an increased risk of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL), although the magnitude of the relative risk is unclear. We estimated the association between familial hematopoietic cancer and risk of lymphoma using validated, registry-based family data, and we also investigated whether associations between some environmental exposures and risk of lymphoma vary between individuals with and without such a family history. Methods: In a population-based case–control study of malignant lymphoma, 1506 case patients and 1229 control subjects were linked to the Swedish Multi-Generation Register and then to the Swedish Cancer Register to ascertain history of cancer in first-degree relatives of patients with malignant lymphoma. Multiple logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations with the risk of lymphoma. Results: A history of hematopoietic malignancy in any first-degree relative was associated with an increased risk of all NHL (OR = 1.8, 95% CI = 1.2 to 2.5), common B-cell NHL subtypes, and HL. Relative risks were generally stronger in association with sibling hematopoietic cancer (OR for all NHL = 3.2, 95% CI = 1.3 to 7.6) than with parental hematopoietic cancer (OR = 1.6, 95% CI = 1.1 to 2.3). A family history of NHL or chronic lymphocytic leukemia (CLL) was associated with an increased risk of several NHL subtypes and HL, whereas familial multiple myeloma was associated with a higher risk of follicular lymphoma. There was no statistically significant heterogeneity in NHL risk associations with environmental factors between individuals with and without familial hematopoietic malignancy. Conclusions: The increased risk of NHL and HL among individuals with a family history of hematopoietic malignancy was approximately twofold for both lymphoma types. There was no evidence that etiologic associations varied between familial NHL and nonfamilial NHL.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Natl Cancer Inst MonogrHome page
B. C.-H. Chiu, Q. Lan, B. J. Dave, A. Blair, S. H. Zahm, and D. D. Weisenburger
The Utility of t(14;18) in Understanding Risk Factors for Non-Hodgkin Lymphoma
J Natl Cancer Inst Monographs, July 1, 2008; 2008(39): 69 - 73.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Czene, H.-O. Adami, and E. T. Chang
Sex- and Kindred-Specific Familial Risk of Non Hodgkin's Lymphoma
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2496 - 2499.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Hjalgrim, K. Ekstrom-Smedby, K. Rostgaard, R.-M. Amini, D. Molin, S. Hamilton-Dutoit, C. Schollkopf, E. T. Chang, E. Ralfkiaer, H.-O. Adami, et al.
Cigarette Smoking and Risk of Hodgkin Lymphoma: A Population-Based Case-Control Study
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1561 - 1566.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. F. Holick
Vitamin D Deficiency
N. Engl. J. Med., July 19, 2007; 357(3): 266 - 281.
[Full Text] [PDF]


Home page
haematolHome page
C. F. Skibola, J. D. Curry, and A. Nieters
Genetic susceptibility to lymphoma
Haematologica, July 1, 2007; 92(7): 960 - 969.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. S. Wang, S. L. Slager, P. Brennan, E. A. Holly, S. De Sanjose, L. Bernstein, P. Boffetta, J. R. Cerhan, M. Maynadie, J. J. Spinelli, et al.
Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)
Blood, April 15, 2007; 109(8): 3479 - 3488.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
B. C.-H. Chiu, B. J. Dave, A. Blair, S. M. Gapstur, J. S. Chmiel, A. J. Fought, S. H. Zahm, and D. D. Weisenburger
Cigarette Smoking, Familial Hematopoietic Cancer, Hair Dye Use, and Risk of t(14;18)-defined Subtypes of Non-Hodgkin's Lymphoma
Am. J. Epidemiol., March 15, 2007; 165(6): 652 - 659.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. S. Wang, J. R. Cerhan, P. Hartge, S. Davis, W. Cozen, R. K. Severson, N. Chatterjee, M. Yeager, S. J. Chanock, and N. Rothman
Common Genetic Variants in Proinflammatory and Other Immunoregulatory Genes and Risk for Non-Hodgkin Lymphoma
Cancer Res., October 1, 2006; 66(19): 9771 - 9780.
[Abstract] [Full Text] [PDF]


Home page
Occup. Environ. Med.Home page
J H Mandel, M A Kelsh, P J Mink, D D Alexander, R M Kalmes, M Weingart, L Yost, and M Goodman
Occupational trichloroethylene exposure and non-Hodgkin's lymphoma: a meta-analysis and review
Occup. Environ. Med., September 1, 2006; 63(9): 597 - 607.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. M. Bracci, T. B. Dalvi, and E. A. Holly
Residential history, family characteristics and non-hodgkin lymphoma, a population-based case-control study in the san francisco bay area.
Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1287 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
E. Negri, R. Talamini, M. Montella, L. Dal Maso, A. Crispo, M. Spina, C. La Vecchia, and S. Franceschi
Family History of Hemolymphopoietic and Other Cancers and Risk of Non-Hodgkin's Lymphoma.
Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 245 - 250.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
E. T. Chang, K. E. Smedby, H. Hjalgrim, B. Glimelius, and H.-O. Adami
Reliability of Self-Reported Family History of Cancer in a Large Case-Control Study of Lymphoma
J Natl Cancer Inst, January 4, 2006; 98(1): 61 - 68.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.